Tuberculosis

In 2018 Tuberculosis killed approximately 1.5 million people worldwide.

Tuberculosis has been around for centuries and has proven highly adaptable and continues to be a problem in many third world countries where access to antibiotics and adequate medical care is often problematic.

As with Malaria, while this is an upcoming project, our goal would be to provide a baseline of vaccine candidates and then to computationally assess each year variations and mutations which make Tuberculosis such a persistent problem.

By providing this baseline and by continually updating a potential range of vaccine candidates we hope to aid in the eradication of Tuberculosis worldwide.

This is an upcoming project.

Please see our other current projects: Covid-19 and Malaria.